免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / 培唑帕尼辅助治疗对术后肾细胞癌的有效性和安全性研究

培唑帕尼辅助治疗对术后肾细胞癌的有效性和安全性研究

登记号 CTR20131447 试验状态 已完成
申请人联系人 诺华肿瘤医学热线 首次公示信息日期 2014-12-18
申请人名称 Glaxo Operations UK Limited/ 葛兰素史克(中国)投资有限公司/ Glaxo Group Limited
一、题目和背景信息
登记号 CTR20131447
相关登记号
药物名称 培唑帕尼
药物类型 化学药物
临床申请受理号 企业选择不公示
适应症 肾细胞癌辅助治疗
试验专业题目 随机、双盲、安慰剂对照、III期研究评价培唑帕尼辅助治疗肾切除术后的局限期肾癌患者的有效性和安全性
试验通俗题目 培唑帕尼辅助治疗对术后肾细胞癌的有效性和安全性研究
试验方案编号 CPZP034D2301 方案最新版本号 V06
版本日期: 2016-04-25 方案是否为联合用药 企业选择不公示
二、申请人信息
申请人名称
1
2
3
联系人姓名 诺华肿瘤医学热线 联系人座机 400-8180600 联系人手机号
联系人Email china.obumi@novartis.com 联系人邮政地址 北京市-北京市-朝阳区针织路23号楼5层 联系人邮编 100004
三、临床试验信息
1、试验目的
评价培唑帕尼作为辅助治疗对肾切除术后局限性或局部进展性肾细胞癌患者的有效性和安全性。
2、试验设计
试验分类 安全性和有效性 试验分期 III期 设计类型 平行分组
随机化 随机化 盲法 双盲 试验范围 国际多中心试验
3、受试者信息
年龄 18岁(最小年龄)至 无岁(最大年龄)
性别 男+女
健康受试者
入选标准
1 诊断为肾细胞癌,组织学为透明细胞或以透明细胞为主型。
2 符合基线期无病状态的标准。
3 器官系统功能良好
4 非转移性疾病(M0)受试者,符合综合2010年版AJCC 病理TNM分期标准和Fuhrman核分级之一:1)pT2,G3或G4,N0;或者 2)pT3,Gany,N0;或者 3)pT4,Gany,N0:或者 4)pTany,Gany,N1
5 过去未接受过针对RCC的辅助治疗或新辅助治疗。
排除标准
1 局部复发RCC、双侧RCC或其它恶性肿瘤病史
2 慢性活动性肝炎的病史,包括乙肝病毒(HBV)或丙肝病毒(HCV)携带者
3 人类免疫缺陷病毒(HIV)感染病史
4 具有临床意义的、可能会增加胃肠道出血风险的胃肠道异常
4、试验分组
试验药
序号 名称 用法
1 中文通用名:培唑帕尼
用法用量:片剂;规格200mg;口服,每天一次,起始剂量每次 600mg, 用药时程,连续用药,共计8到12周;然后根据受试者的安全性和耐受性,由研究者根据方案规定决定是否增加到800mg剂量水平或者保持600mg剂量水平。治疗总时程为12个月。
对照药
序号 名称 用法
1 中文通用名:安慰剂
用法用量:片剂;规格200mg;口服,每天一次,起始剂量每次 600mg, 用药时程,连续用药,共计8到12周;然后根据受试者的安全性和耐受性,由研究者根据方案规定决定是否增加到800mg剂量水平或者保持600mg剂量水平。治疗总时程为12个月。
5、终点指标
主要终点指标及评价时间
序号 指标 评价时间 终点指标选择
1 无病生存期(DFS) 当获得578个DFS事件时进行评价。 有效性指标
次要终点指标及评价时间
序号 指标 评价时间 终点指标选择
1 总生存期(OS) 当获得578个DFS事件时进行评价。 有效性指标
2 生活质量 当获得578个DFS事件时进行评价。 有效性指标+安全性指标
3 安全性和耐受性 当获得578个DFS事件时进行评价。 安全性指标
4 年DFS率(如1年、2年等) 当获得578个DFS事件时进行评价。 有效性指标
6、数据安全监查委员会(DMC)
7、是否购买保险
四、研究者信息
1、主要研究者信息
1 姓名 叶定伟 学位 医学博士 职称 主任医师
电话 021-64438650 Email dwye@shca.org.cn 邮政地址 上海市-上海市-徐汇区东安路270号
邮编 200032 单位名称 复旦大学附属肿瘤医院
2、各参加机构信息
序号 机构名称 主要研究者 国家或地区 省(州) 城市
1 复旦大学附属肿瘤医院 叶定伟 中国 上海市 上海市
2 中国医学科学院肿瘤医院 王金万 中国 北京 北京
3 上海交通大学医学院附属仁济医院 黄翼然 中国 上海 上海
4 天津肿瘤医院 姚欣 中国 天津 天津
5 北京大学第三医院 马潞林 中国 北京 北京
6 浙江大学医学院附属第一医院 谢立平 中国 浙江 杭州
7 复旦大学附属华山医院 丁强 中国 上海 上海
8 浙江大学医学院附属第二医院 杜传军 中国 浙江 杭州
9 上海瑞金医院 沈周俊 中国 上海 上海
10 华中科技大学同济医学院附属同济医院 叶章群 中国 湖北 武汉
11 复旦大学附属肿瘤医院 叶定伟 中国 上海 上海
12 COIBA Centro de oncología e investig-Berazategui Novartis' Investigator Argentina Buenos Aires Berazategui
13 Instituto Alexander Fleming-Capital Federal Novartis' Investigator Argentina Buenos Aires Capital Federal
14 Hospital Alemán-Ciudad de Buenos Aires Novartis' Investigator Argentina Buenos Aires Ciudad de Buenos Aires
15 Instituto de Investigaciones Clinicas Cipolletti-Cipolletti Novartis' Investigator Argentina Río Negro Cipolletti
16 CER Instituto Medico-Quilmes Novartis' Investigator Argentina Quilmes Quilmes
17 Instituto Oncologico de Cordoba-Cordoba Novartis' Investigator Argentina Córdova Córdoba
18 Instituto Médico Especializado-Ciudad de Buenos Aires Novartis' Investigator Argentina Buenos Aires Ciudad de Buenos Aires
19 Centro Oncologico de Rosario-Rosario Novartis' Investigator Argentina Santa Fe Rosario
20 CEMIC-Ciudad Autonoma de Bueno Novartis' Investigator Argentina Buenos Aires Ciudad Autonoma de Bueno
21 Hospital Britanico de Buenos Aires-Ciudad Autónoma de Bueno Novartis' Investigator Argentina Buenos Aires Ciudad Autonoma de Buenos Aires
22 Fundacion RUSCULLEDA-Córdoba Novartis' Investigator Argentina Córdova Córdoba
23 ISIS Clinica Especializada-Santa Fe Novartis' Investigator Argentina Santa Fe Santa Fe
24 Sanatorio de la Providencia-Ciudad Autonoma de Bueno Novartis' Investigator Argentina Buenos Aires Ciudad Autónoma de Buenos Aires
25 Investigaciones Clinicas Ciudad Autonoma de Buenos-Buenos Aires Novartis' Investigator Argentina Buenos Aires Ciudad Autónoma de Buenos Aires
26 Centro Medico San Roque-San Miguel de Tucuman Novartis' Investigator Argentina San Miguel de Tucumán San Miguel de Tucumán
27 Universitaetsklinik Innsbruck-Innsbruck Novartis' Investigator Austria Innsbruck Innsbruck
28 LKH Salzburg-Salzburg Novartis' Investigator Austria Salzburg Salzburg
29 LKH Salzburg-Salzburg Novartis' Investigator Austria Salzburg Salzburg
30 AKH Wien-Vienna Novartis' Investigator Austria Vienna Vienna
31 LKH Graz-Graz Novartis' Investigator Austria Graz Graz
32 KH Hietzing mit Neurolog. Zentrum Rosenhügel-Vienna Novartis' Investigator Austria Vienna Vienna
33 Centre Hospitalier Universitaire de Liège-Liege Novartis' Investigator Belgium Liège Liège
34 Clinique St Elisabeth-Namur Novartis' Investigator Belgium Namur Namur
35 AZ St Augustinus-Wilrijk Novartis' Investigator Belgium Wilrijk Wilrijk
36 UZ Brussel-Brussel Novartis' Investigator Belgium Jette Jette
37 Heilig Hart Ziekenhuis 3-Roeselare Novartis' Investigator Belgium Roeselare Roeselare
38 JESSA Ziekenhuis Campus Virga Jesse-Hasselt Novartis' Investigator Belgium Hasselt Hasselt
39 Hospital Erasto Gaertner-Curitiba Novartis' Investigator Brazil Paraná Curitiba
40 Hospital Israelita Albert Einstein-Sao Paulo Novartis' Investigator Brazil Sao Paulo Sao Paulo
41 Hospital das Clínicas da Universidade Federal-Belo Horizonte Novartis' Investigator Brazil Minas Gerais Belo Horizonte
42 Instituto Nacional do Cancer - INCA-Rio de Janeiro Novartis' Investigator Brazil Rio De Janeiro Rio de Janeiro
43 Hospital Sirio Libanes-Sao Paulo Novartis' Investigator Brazil Sao Paulo Sao Paulo
44 Universidade Estadual de Campinas (UNICAMP)-Campinas Novartis' Investigator Brazil Sao Paulo Campinas
45 Hospital Universitário Pedro Ernesto-UERJ-Rio de Janeiro Novartis' Investigator Brazil Rio De Janeiro Rio De Janeiro
46 Instituto do Cancer do Estado de Sao Paulo-Sao Paulo Novartis' Investigator Brazil Sao Paulo Sao Paulo
47 Fundacao PIO XII - Hospital de Cancer de Barretos-Barretos Novartis' Investigator Brazil Sao Paulo Barretos
48 Clinica de Oncologia Medica-Sao Paulo Novartis' Investigator Brazil Sao Paulo Sao Paulo
49 Hospital de Caridade de Ijui-Ijui Novartis' Investigator Brazil Rio Grande Do Sul Ijui
50 Hospital santa marcelina-Sao Paulo Novartis' Investigator Brazil Sao Paulo Sao Paulo
51 PUC-RS/Hospital Sao Lucas-Porto Alegre Novartis' Investigator Brazil Rio Grande Do Sul Porto Alegre
52 Cross Cancer Institute-Edmonton Novartis' Investigator Canada Alberta Edmonton
53 Tom Baker Cancer Centre-Calgary Novartis' Investigator Canada Alberta Calgary
54 London Health Sciences Centre- Lawson Health-London Novartis' Investigator Canada Ontario London
55 Ottawa Regional Cancer Centre-Ottawa Novartis' Investigator Canada Ontario Ottawa
56 Lakeridge Health-Oshawa Novartis' Investigator Canada Ontario Oshawa
57 Princess Margaret Hospital-Toronto Novartis' Investigator Canada Ontario Toronto
58 CHUQ-Hotel Dieu de Quebec-Quebec Novartis' Investigator Canada Québec Québec
59 The Moncton Hospital-Moncton Novartis' Investigator Canada New Brunswick Moncton
60 Queen Elizabeth II Health Sciences Centre 2-Halifax Novartis' Investigator Canada Nova Scotia Halifax
61 Juravinski Cancer Centre-Hamilton Novartis' Investigator Canada Ontario Hamilton
62 CHUM Hopital Notre Dame-Quebec Novartis' Investigator Canada Québec Montreal
63 Vancouver Prostate Centre-Vancouver Novartis' Investigator Canada British Columbia Vancouver
64 Sunnybrook Health Sciences Centre-Toronto Novartis' Investigator Canada Ontario Toronto
65 Fundación Arturo López Pérez-Santiago-Chile-C Novartis' Investigator Chile Región Metro De Santiago Santiago
66 Instituto Oncologico-Vina del Mar-Chile-C Novartis' Investigator Chile Valparaíso Vina del Mar
67 Masarykova nemocnice-Usti nad Labem-Czech Republic-C Novartis' Investigator Czech Republic Usti nad Labem Usti nad Labem
68 VFN Praha 2-Praha 2-Czech Republic-C Novartis' Investigator Czech Republic Praha 2 Praha 2
69 Nemocnice Na Bulovce-Praha 8-Czech Republic-C Novartis' Investigator Czech Republic Praha 8 Praha 8
70 FNsP u sv. Anny-Brno-Czech Republic-C Novartis' Investigator Czech Republic Brno Brno
71 FN Plzen 2-Plzen-Czech Republic-C Novartis' Investigator Czech Republic Plzen Plzen
72 FN Hradec Kralove 5-Hradec Kralove-Czech Republic-C Novartis' Investigator Czech Republic Hradec Kralove Hradec Kralove
73 FN Olomouc-Olomouc-Czech Republic-C Novartis' Investigator Czech Republic Olomouc Olomouc
74 FNsP Ostrava- Poruba-Ostrava - Poruba-Czech Republic-C Novartis' Investigator Czech Republic Ostrava - Poruba Ostrava - Poruba
75 Masarykuv onkologicky ustav-Brno-Czech Republic-C Novartis' Investigator Czech Republic Brno Brno
76 Nemocnice Novy Jicin-Novy Jicin-Czech Republic-C Novartis' Investigator Czech Republic Novy Jicin Novy Jicin
77 Herlev Hospital-Herlev-Denmark-C Novartis' Investigator Denmark Herlev Herlev
78 Aarhus Universitetshospital, Aarhus Sygehus-Aarhus-Denmark-C Novartis' Investigator Denmark Aarhus Aarhus
79 Odense Universitetshospital-Odense C-Denmark-C Novartis' Investigator Denmark Odense C Odense C
80 Centre Francois Baclesse-Caen cedex 5-France-C Novartis' Investigator France Caen Cedex 05 Caen Cedex 05
81 Institut Mutualiste Montsouris-Paris-France-C Novartis' Investigator France Paris Paris
82 Centre Eugène Marquis-Rennes-France-C Novartis' Investigator France Rennes Rennes
83 CHU de Poitiers - Hopital de la Milétrie-Poitiers cedex-France-C Novartis' Investigator France Poitiers Cedex Poitiers Cedex
84 HUS - Nouvel Hopital Civil-Strasbourg cedex-France-C Novartis' Investigator France Strasbourg Cedex Strasbourg Cedex
85 Institut de Cancérologie Paul Papin-Angers cedex 9-France-C Novartis' Investigator France Angers cedex 9 Angers cedex 9
86 Institut Cancérologie de l’Ouest - René Gauducheau-Saint-Herblain cedex-France-C Novartis' Investigator France Saint Herblain Saint Herblain
87 Hopital Européen Georges Pompidou-Paris cedex 15-France-C Novartis' Investigator France Paris Cedex 15 Paris Cedex 15
88 Polyclinique Courlancy-Reims-France-C Novartis' Investigator France Reims Reims
89 CHRU de Tours - Hopital Bretonneau-Tours cedex 9-France-C Novartis' Investigator France Tours Cedex 9 Tours Cedex 9
90 Clinique Sainte Marguerite-Hyeres-France-C Novartis' Investigator France Hyeres Hyeres
91 CHU de Montpellier - Hopital Saint-Eloi-Montpellier cedex 5-France-C Novartis' Investigator France Montpellier Cedex 5 Montpellier Cedex 5
92 CHU de Bordeaux - Hopital Saint André-Bordeaux-France-C Novartis' Investigator France Bordeaux Bordeaux
93 Centre Léon Bérard-Lyon cedex 08-France-C Novartis' Investigator France Lyon Cedex 08 Lyon Cedex 08
94 CHU de Marseille - Hopital de la Timone-Marseille cedex 5-France-C Novartis' Investigator France Marseille cedex 5 Marseille cedex 5
95 CHU de Besancon - Hopital Jean Minjoz-Besancon cedex-France-C Novartis' Investigator France Besancon cedex Besancon cedex
96 Centre Jean Bernard - Clinique Victor Hugo-Le Mans-France-C Novartis' Investigator France Le Mans Le Mans
97 Clinique Pasteur-Toulouse-France-C Novartis' Investigator France Toulouse Toulouse
98 Clinique Sainte Anne-Strasbourg cedex-France-C Novartis' Investigator France Strasbourg cedex Strasbourg cedex
99 Gem. Praxis Drs. Woerner und Rudolph-Kirchheim-Germany-C Novartis' Investigator Germany Baden-Wuerttemberg Kirchheim
100 Universitaetsklinikum Marburg-Urologie-Marburg-Germany-C Novartis' Investigator Germany Hessen Marburg
101 Praxis Dr. med. Jochen Wilke-Fuerth-Germany-C Novartis' Investigator Germany Bayern Fuerth
102 Helios Klinikum Erfurt-Urologie-Erfurt-Germany-C Novartis' Investigator Germany Freistaat Thüringen Erfurt
103 Universitaetsklinikum Bonn-Urologie-Bonn-Germany-C Novartis' Investigator Germany Nordrhein-Westfalen Bonn
104 Klinikum Offenbach GmbH-Urologische Klinik-Offenbach-Germany-C Novartis' Investigator Germany Hessen Offenbach
105 Universitaetsklinikum Muenster-Urologie-Muenster-Germany-C Novartis' Investigator Germany Nordrhein-Westfalen Muenster
106 Uniklinik Schleswig-Holstein-Campus Luebeck-Urolog-Luebeck-Germany-C Novartis' Investigator Germany Schleswig-Holstein Luebeck
107 Universitaetsklinikum des Saarlandes-Urologie-Homburg/Saar-Germany-C Novartis' Investigator Germany Saarland Homburg
108 Universitaetsklinikum Ulm-Urologie-Ulm-Germany-C Novartis' Investigator Germany Baden-Wuerttemberg Ulm
109 Praxis Dr. med. Ralf Eckert-Eisleben-Germany-C Novartis' Investigator Germany Sachsen-Anhalt Eisleben
110 Charite-Campus Mitte-Urologie-Berlin-Germany-C Novartis' Investigator Germany Berlin Berlin
111 Universitaetsklinikum Aachen-Urologie-Aachen-Germany-C Novartis' Investigator Germany Nordrhein-Westfalen Aachen
112 Praxis Dr. med. Goetz Geiges-Berlin-Germany-C Novartis' Investigator Germany Berlin Berlin
113 Katharinenhospital Stuttgart-Stuttgart-Germany-C Novartis' Investigator Germany Baden-Wuerttemberg Stuttgart
114 Universitaetsklinikum Jena-Urologie-Jena-Germany-C Novartis' Investigator Germany Thueringen Jena
115 Krankenhaus Am Urban-Berlin-Germany-C Novartis' Investigator Germany Berlin Berlin
116 Waldkrankenhaus St. Marien-Erlangen-Germany-C Novartis' Investigator Germany Bayern Erlangen
117 Praxis Dr. med. Toralf Kellner-Plauen-Germany-C Novartis' Investigator Germany Sachsen Plauen
118 Klinikum rechts der Isar-Urologie-Muenchen-Germany-C Novartis' Investigator Germany Bayern Muenchen
119 Klinikum der J. W. Goethe-Universitaet-Med. K. II-Frankfurt-Germany-C Novartis' Investigator Germany Hessen Frankfurt
120 Kreiskrankenhaus Sigmaringen-Urologie-Sigmaringen-Germany-C Novartis' Investigator Germany Baden-Wuerttemberg Sigmaringen
121 Praxis Dr. med. Hans Werner Tessen-Goslar-Germany-C Novartis' Investigator Germany Niedersachsen Goslar
122 Universitaetsklinikum der GHS Essen-Tumorforschung-Essen-Germany-C Novartis' Investigator Germany Nordrhein-Westfalen Essen
123 Martin-Luther-Universitaet Halle-Urologie-Halle-Germany-C Novartis' Investigator Germany Sachsen-Anhalt Halle
124 Johannes-Gutenberg-Universitaet Mainz-Urologie-Mainz-Germany-C Novartis' Investigator Germany Rheinland-Pfalz Mainz
125 Studienzentrum Onkologie Ravensburg im Brustzentru-Ravensburg-Germany-C Novartis' Investigator Germany Baden-Wuerttemberg Ravensburg
126 Staedtische Kliniken Neuss Lukaskrankenhaus-Urol.-Neuss-Germany-C Novartis' Investigator Germany Nordrhein-Westfalen Neuss
127 Caritas-Krankenhaus St. Josef-Urologie-Regensburg-Germany-C Novartis' Investigator Germany Bayern Regensburg
128 Duisburger Fachaerztegemeinschaft Urologie-Duisburg-Germany-C Novartis' Investigator Germany Nordrhein-Westfalen Duisburg
129 Klinikum Nordoberpfalz-Weiden-Urologie-Weiden-Germany-C Novartis' Investigator Germany Bayern Weiden
130 Zeisigwaldkliniken Bethanien-Urologie-Chemnitz-Germany-C Novartis' Investigator Germany Sachsen Chemnitz
131 Universitaetsklinikum Eppendorf-Urologie-Hamburg-Germany-C Novartis' Investigator Germany Hamburg Hamburg
132 Medizinische Hochschule Hannover-Urologie-Hannover-Germany-C Novartis' Investigator Germany Niedersachsen Hannover
133 Diakonissenkrankenhaus Dessau gGmbH-Urologie-Dessau-Germany-C Novartis' Investigator Germany Sachsen-Anhalt Dessau
134 Klinikum Bremen-Mitte gGmbH-Urologische Klinik-Bremen-Germany-C Novartis' Investigator Germany Bremen Bremen
135 Universitaetsklinikum Tuebingen-Urologie-Tuebingen-Germany-C Novartis' Investigator Germany Baden-Wuerttemberg Tuebingen
136 Klinikum Braunschweig-Urologische Klinik-Braunschweig-Germany-C Novartis' Investigator Germany Niedersachsen Braunschweig
137 Kliniken Maria Hilf-Klinik fuer Urologie-Moenchengladbach-Germany-C Novartis' Investigator Germany Nordrhein-Westfalen Moenchengladbach
138 Marien-Krankenhaus-Bergisch Gladbach-Germany-C Novartis' Investigator Germany Nordrhein-Westfalen Bergisch Gladbach
139 Gem. Praxis Drs. Nusch und Kalhori-Velbert-Germany-C Novartis' Investigator Germany Nordrhein-Westfalen Velbert
140 Klinikum Grosshadern-Urologie-Muenchen-Germany-C Novartis' Investigator Germany Bayern Muenchen
141 VITURO, Ges.f. klinische Studien, Ur-Leipzig-Germany-C Novartis' Investigator Germany Sachsen Leipzig
142 University Hospital of Patras-Patra-Greece-C Novartis' Investigator Greece Rio-Patras Rio-Patras
143 University Hospital of Heraklion-Heraklion, Crete-Greece-C Novartis' Investigator Greece Heraklion, Crete Heraklion, Crete
144 General Hospital of Athens Novartis' Investigator Greece<